Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MARNEVO-Covid: Neurodegeneration Markers in Severe Covid-19
NCT04361344Terminated
- Sponsor
- Centre Hospitalier de Pau
- Start
- May 2020
- Primary completion
- Oct 2020
- Countries
- 1
01
Overview
Single-arm trial, sponsored by Centre Hospitalier de Pau. Primary endpoints: Neurofilament Light Chain Level at Day 7 and Glial Fibrillary Acidic Protein Level at Day 7. Started May 2020; status: terminated.
Beyond the preview
Go deeper on NCT04361344.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04361344.